Alkyl amines improve detection of components of formaldehyde-fixed biological samples

US9400235B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9400235-B2
Application numberUS-201314139837-A
CountryUS
Kind codeB2
Filing dateDec 23, 2013
Priority dateMar 30, 2007
Publication dateJul 26, 2016
Grant dateJul 26, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Alkyl amines act to release formaldehyde cross-linking that occurs in biological samples. Thus, contacting alkyl amines to formaldehyde fixed samples is a useful way to render biological components of the samples, including nucleic acids or proteins, more accessible to detection and characterization.

First claim

Opening claim text (preview).

What is claimed is: 1. A reaction mixture comprising, formaldehyde cross-linked biological sample; and a sufficient amount of an alkyl amine selected from the group consisting of ethylenediamine and propylamine to release at least a portion of a cross-linked component of the formaldehyde cross-linked biological sample. 2. The reaction mixture of claim 1 , wherein the amount of alkyl amine is between 0.01% and 5%. 3. The reaction mixture of claim 1 , wherein the alkyl amine is ethylenediamine. 4. The reaction mixture of claim 1 , wherein the alkyl amine is propylamine. 5. The reaction mixture of claim 1 , wherein the biological sample is a tissue sample from an animal. 6. The reaction mixture of claim 1 , comprising a protease. 7. The reaction mixture of claim 6 , wherein the protease is proteinase K.

Assignees

Inventors

Classifications

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • G01N1/30Primary

    Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis} · CPC title

  • Crosslinking agents, e.g. psoralen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9400235B2 cover?
Alkyl amines act to release formaldehyde cross-linking that occurs in biological samples. Thus, contacting alkyl amines to formaldehyde fixed samples is a useful way to render biological components of the samples, including nucleic acids or proteins, more accessible to detection and characterization.
Who is the assignee on this patent?
Roche Molecular Systems Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).